Héctor Castro

Héctor Castro, MD, Senior Technical Director of Pharmaceutical Economics and Financing at MSH, has nearly 20 years of global health experience with a focus on health systems strengthening in quality assurance, assessment, health financing, strategic purchasing, and provision of health care technologies (including medicines, devices, and procedures). Before joining MSH, Dr. Castro served as chief officer, technical advisor, director, and manager in strategic planning, quality assurance, health, safety, and environment for various pharmaceutical, health insurance, and nongovernmental organizations.

Dr. Castro is former founding Chief Executive Director of the HTA Institute of Colombia and Director of Medicines and Technologies at the Ministry of Health and Social Protection of Colombia. He currently serves on the Board of Directors of the Health Technology Assessment International, a prominent international network in the field of health technology assessment. Dr. Castro has an MSc in Health Policy, Planning, and Financing from the London School of Economics & Political Science, is a Doctor in Public Health and Policy/Health Economics from the London School of Hygiene & Tropical Medicine, and was a Takemi Postdoctoral Fellow at the Harvard T.H. Chan School of Public Health.